Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Sales | 31,893 | 20,459 |
| Gross Profit | 31,893 | 20,459 |
| Operating Expenses | 266,958 | 217,398 |
| Operating Income | -235,065 | -196,939 |
| Interest Expense | 1,136 | 2,118 |
| Other Income | 13,399 | 17,885 |
| Pre-tax Income | -222,802 | -181,172 |
| Income Tax | 163 | 212 |
| Net Income Continuous | -222,965 | -181,384 |
| Minority Interests | -19,811 | -7,613 |
| Net Income | $-203,154 | $-173,771 |
| EPS Basic Total Ops | -7.57 | -6.66 |
| EPS Basic Continuous Ops | -6.76 | -5.65 |
| EPS Diluted Total Ops | -7.57 | -6.66 |
| EPS Diluted Continuous Ops | -6.76 | -5.65 |
| EBITDA(a) | $-224,670 | $-187,038 |